De-escalation in HPV-negative locally advanced head and neck squamous cell cancer (LA-HNSCC) in patients after induction chemotherapy: A retrospective case series

被引：1
|
作者：
Brisson, Ryan J.
Kochanny, Sara
Foster, Corey Christian
Vokes, Everett E.
Haraf, Daniel J.
Seiwert, Tanguy Y.
机构：
[1] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA
[2] Univ Chicago Med, Hematol Oncol Sect, Dept Med, Chicago, IL USA
[3] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
[4] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e18090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18090
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pembrolizumab plus chemoradiation (CRT) for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Phase 3 KEYNOTE-412 trial
    Machiels, J-P.
    Licitra, L.
    Rischin, D.
    Waldron, J.
    Burtness, B.
    Gregoire, V.
    Shekar, T.
    Brown, H. M.
    Cheng, J.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [32] DURTRERAD: A phase II open-label study evaluating feasibility and efficacy of durvalumab (D) and durvalumab plus tremelimumab (DT) in combination with radiotherapy (RT) in non-resectable locally advanced HPV-negative head and neck squamous cell carcinoma (LA-HNSCC)
    Keilholz, Ulrich
    Gauler, Thomas Christoph
    Stromberger, Carmen
    Kofla, Grzegorz
    De Wit, Maike
    Mette, Ramona
    Burock, Susen
    Klinghammer, Konrad Friedrich
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Induction Chemotherapy with Cisplatin, Paclitaxel, and Capecitabine (PTC) in Locally Advanced (LA) Squamous Cell Carcinoma of Head and Neck (SCCHN)
    Alvarado-Munoz, J. F.
    Reyes-Morales, A.
    Puac-Polanco, V.
    Bruixola, G.
    Chivalan, M.
    Torselli, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E26 - E26
  • [34] Early prediction of survival using FDG-PET/CT after 2 courses of induction chemotherapy in patients with locally advanced head and neck squamous cell carcinomas (HNSCC)
    Abgral, Ronan
    Keromnes, Nathalie
    Le Roux, Pierre-Yves
    Rousset, Jean
    Danhier, Serge
    Nowak, Emmanuel
    Querellou, Solene
    Salaun, Pierre
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [35] Predictors of toxicity to concurrent chemoradiation (CRT) in patients (pts) with locally advanced head and neck squamous cell cancer (HNSCC)
    Yelamanchili, R.
    Hotte, S.
    Julian, J.
    Wright, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Correlation of deviation from intended cisplatin (CDDP) dose intensity with outcome in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) receiving concurrent chemoradiation (CRT)
    Liu, C. S.
    Elser, C.
    Huang, S.
    Pond, G. R.
    O'Sullivan, B.
    Chen, E. X.
    Waldron, J. N.
    Goldstein, D.
    Siu, L. L.
    Kim, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Influence of induction chemotherapy on patients' compliance to radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.
    Atassi, B.
    Ozgursoy, O.
    Yoo, G. H.
    Jacobs, J. R.
    Bhatti, N. S.
    Mal, M.
    Kim, H.
    Lin, H.
    Sukari, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Nimotuzumab in combination with intensity modulated radiotherapy improve survival in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A multicenterbased real-world study
    Yi, Junlin
    Lang, Jin Yi
    Zhang, Chenping
    Zhang, Xin-Xin
    Wu, Shao-xiong
    Sun, Yan
    Wang, Peiguo
    Qiu, Sufang
    Huang, Xiaodong
    Zhang, Peng
    Ren, Guoxin
    Liu, Kun
    Du, Xiao-Jing
    Xiao, Shaowen
    Wang, Zhong Qiu
    Weng, Youliang
    Zhang, Ye
    Zhou, Hang
    Tu, Wenyong
    Bai, Xianhong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Efficacy and Safety of Aprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC): A Phase 2 Trial
    Zhang, Y.
    Yi, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S108 - S109
  • [40] Response-adaptive resection following neoadjuvant penpulimab combined with chemotherapy in HPV-negative operable locally advanced head and neck squamous cell: A phase II clinical trial
    Yang, Kunyu
    Zhang, Xiaomeng
    Zhang, Zhanjie
    Wu, Bian
    Huang, Jing
    Peng, Gang
    Jia, Yulin
    Xiao, Guixiang
    Ma, Hui
    Wen, Lu
    Hu, Yuan
    Zhao, Xueyan
    Zhou, Yan
    Hong, Xiaohua
    Shi, Liangliang
    Ding, Qian
    Zhong, Yi
    Xu, Zhi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345